Prescription Drugs Sometimes Have Cancer-Causing Contaminants

Anything that you ingest is subject to oversight and regulation. Medications that claim to treat or prevent different conditions are subject to far more review and oversight than foods for beauty products.

Companies producing drugs have to carefully study both their effectiveness and any negative side effects they produce. They also have to take great care to manufacture drugs with consistent formulation and potency for the safety of consumers.

Unfortunately, drug manufacturers don’t always pay close attention to the products they turn out, which can lead to problems for consumers. Recent drug recalls have highlighted how serious contamination issues can be in the prescription medication world.

Independent Labs Keep Finding Carcinogens in Popular Medicines

Numerous popular medications have been recalled in recent years. Several of these recalls have specifically involved the presence of known carcinogens in medicines.

These carcinogens are often a byproduct of the chemical process used to manufacture the active ingredient in the drugs. Since 2018, numerous recalls have stemmed from the presence of a particular chemical byproduct known as NDMA (N-nitrosadimethylamine) in certain blood pressure medications. This contaminant keeps showing up in third-party tests and making people question the safety of these drugs.

The drug company Pfizer recently announced that it was temporarily pausing the distribution of its drug Chantix because of the presence of this chemical contaminant. Those who simply want to stop smoking may have unknowingly ingested a dangerous amount of a chemical that could cause cancer.

Patients taking the drug for health reasons should not have to worry about that drug later causing another, even worse medical condition. If you’ve been harmed by a defective drug, it’s wise to find out what your legal options are.